美国国防部-2023生物防御态势审查（英）-2023-56页_1mb

2023 Biodefense Posture Review Summary

The 2023 Biodefense Posture Review (BPR) for the Department of Defense (DoD) aims to address growing biological threats by enhancing preparedness, response, and collaboration. It builds on the 2022 National Defense Strategy (NDS) and lessons from the COVID-19 pandemic to posture DoD for biothreats through 2035.

Purpose and Context

• The DoD faces unprecedented biological threats from natural, accidental, and deliberate sources due to advances in biotechnology and climate change.
• Key objectives include reducing risks, improving resilience, and supporting national biodefense efforts.
• COVID-19 response lessons informed reforms, highlighting gaps in readiness, supply chains, and interagency coordination.

Identified Threats

• Biothreat Landscape: Includes emerging infectious diseases, laboratory accidents, and deliberate biological weapons use by adversaries like China, Russia, and North Korea.
• Challenges: Decentralized enterprise, limited situational awareness, and risks from rapid technological evolution.
• Evolution: Growing potential for novel pathogens and synthetic biology increase threat complexity.

Strategic Approach and Reforms

• Four Lines of Effort:
  • Enhance early warning and understanding of biothreats.
  • Improve preparedness for a resilient Total Force.
  • Speed response to mitigate impacts on DoD missions.
  • Coordinate and collaborate with allies, partners, and interagency.
• Biodefense Council: Established to integrate authorities, clarify roles, and oversee reforms.
• Alignment with NBS: Supports national goals for risk awareness, prevention, preparedness, response, and recovery.

Key Recommendations and Actions

• Governance: Strengthen DoD-wide coordination through the Biodefense Council to standardize priorities and investments.
• Biosurveillance: Expand early detection systems, integrate data, and enable real-time threat characterization.
• Training and Preparedness: Elevate biodefense training in exercises, prioritize requirements, and modernize R&D.
• Response Capabilities: Improve materiel readiness, supply chain resilience, and industrial base partnerships.
• Collaboration: Enhance international and interagency efforts to detter bioweapons, share intelligence, and address global health security.

Lessons from COVID-19

• Response highlighted shortfalls in logistics, PPE stockpiles, and data sharing.
• Reforms focus on faster capability development, better resource allocation, and integrated supply chains.

Annex Overview

• Definitions: Clarifies biodefense, biothreats, and related terms.
• COVID-19 Lessons: Incorporated recommendations from reports to improve future bioincident responses.